{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T08:13:29Z","timestamp":1794903209979,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clineuro.2025.108952","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T06:39:20Z","timestamp":1747291160000},"page":"108952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The impact of semaglutide use for weight loss on transforaminal lumbar interbody fusion outcomes"],"prefix":"10.1016","volume":"254","author":[{"given":"Syed I.","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5860-610X","authenticated-orcid":false,"given":"Pranav","family":"Mirpuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Massaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9681-4695","authenticated-orcid":false,"given":"Ryan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladine","family":"Elsamadicy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owoicho","family":"Adogwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2025.108952_bib1","article-title":"GLP\u22121 receptor agonists for the treatment of obesity: role as a promising approach","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108952_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.clineuro.2025.108952_bib3","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.clineuro.2025.108952_bib4","doi-asserted-by":"crossref","unstructured":"X. Pi-Sunyer, A. Astrup, K. Fujioka, , A randomized, controlled trial of 3.0 mg of liraglutide in weight management. \u3008https:\/\/doi-org.rosalindfranklin.idm.oclc.org\/10.1056\/NEJMoa1411892\u3009. DOI: 10.1056\/NEJMoa1411892.","DOI":"10.1056\/NEJMoa1411892"},{"issue":"11","key":"10.1016\/j.clineuro.2025.108952_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108952_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti obesity drug discovery: advances and challenges","volume":"21","author":"M\u00fcller","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.clineuro.2025.108952_bib7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/oby.22794","article-title":"Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5","volume":"28","author":"Kushner","year":"2020","journal-title":"Obesity"},{"issue":"14","key":"10.1016\/j.clineuro.2025.108952_bib8","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the step 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.clineuro.2025.108952_bib9","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the step 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clineuro.2025.108952_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2025.108952_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clineuro.2018.12.012","article-title":"Impact of obesity on outcomes following lumbar spine surgery: a systematic review and meta-analysis","volume":"177","author":"Goyal","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108952_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0035-1570750","article-title":"The effects of obesity on spine surgery: a systematic review of the literature","volume":"6","author":"Jackson","year":"2016","journal-title":"Glob. Spine J."},{"issue":"4","key":"10.1016\/j.clineuro.2025.108952_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cmet.2016.02.005","article-title":"Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity","volume":"23","author":"Magkos","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.clineuro.2025.108952_bib14","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.2147\/DDDT.S381546","article-title":"An effective glucagon-like peptide-1 receptor agonists, semaglutide, improves sarcopenic obesity in obese mice by modulating skeletal muscle metabolism","volume":"16","author":"Ren","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"issue":"6","key":"10.1016\/j.clineuro.2025.108952_bib15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2214\/AJR.18.20441","article-title":"Paraspinal lean muscle mass measurement using spine mri as a predictor of adjacent segment disease after lumbar fusion: a propensity score\u2013matched case-control analysis","volume":"212","author":"Chang","year":"2019","journal-title":"Am. J. Roentgenol."},{"issue":"8","key":"10.1016\/j.clineuro.2025.108952_bib16","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/jor.24829","article-title":"Preoperative paraspinal neck muscle characteristics predict early onset adjacent segment degeneration in anterior cervical fusion patients: a machine-learning modeling analysis","volume":"39","author":"Wong","year":"2021","journal-title":"J. Orthop. Res. Publ. Orthop. Res. Soc."},{"issue":"7","key":"10.1016\/j.clineuro.2025.108952_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.spinee.2016.03.010","article-title":"Paraspinal muscle, facet joint, and disc problems: risk factors for adjacent segment degeneration after lumbar fusion","volume":"16","author":"Kim","year":"2016","journal-title":"Spine J. Off. J. N. Am. Spine Soc."},{"issue":"2","key":"10.1016\/j.clineuro.2025.108952_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/medicina58020224","article-title":"The impact of GLP1 agonists on bone metabolism: a systematic review","volume":"58","author":"Daniilopoulou","year":"2022","journal-title":"Medicina"},{"issue":"12","key":"10.1016\/j.clineuro.2025.108952_bib19","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00198-018-4649-8","article-title":"Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials","volume":"29","author":"Zhang","year":"2018","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108952_bib20","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/JOE-17-0278","article-title":"Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists","volume":"236","author":"Mabilleau","year":"2018","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.clineuro.2025.108952_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-023-01150-8","article-title":"Narrative review of effects of glucagon-like peptide-1 receptor agonists on bone health in people living with obesity","author":"Herrou","year":"2023","journal-title":"Calcif. Tissue. Int."},{"issue":"8","key":"10.1016\/j.clineuro.2025.108952_bib22","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2015-1176","article-title":"GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women","volume":"100","author":"Iepsen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clineuro.2025.108952_bib23","doi-asserted-by":"crossref","unstructured":"M.S. Hansen, E.M. W\u00f6lfel, S. Jeromdesella, , The effect of semaglutide on bone turnover in adults with increased fracture risk: a randomised, double-blinded, placebo-controlled trial, 2023. DOI: 10.2139\/ssrn.4647909.","DOI":"10.2139\/ssrn.4647909"},{"issue":"13","key":"10.1016\/j.clineuro.2025.108952_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/BRS.0000000000004682","article-title":"Bariatric surgery before spine surgery is associated with fewer postsurgical complications: a systematic review and meta-analysis","volume":"48","author":"Gupta","year":"2023","journal-title":"Spine"},{"key":"10.1016\/j.clineuro.2025.108952_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.wneu.2022.11.049","article-title":"Clinical outcomes of bariatric surgery before spinal fusion: a systematic review","volume":"170","author":"Luxenburg","year":"2023","journal-title":"World Neurosurg."},{"issue":"9","key":"10.1016\/j.clineuro.2025.108952_bib26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.spinee.2018.01.023","article-title":"Bariatric surgery before elective posterior lumbar fusion is associated with reduced medical complications and infection","volume":"18","author":"Jain","year":"2018","journal-title":"Spine J."},{"issue":"0","key":"10.1016\/j.clineuro.2025.108952_bib27","first-page":"null","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"0","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clineuro.2025.108952_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bja.2020.10.023","article-title":"Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus","volume":"126","author":"Hulst","year":"2021","journal-title":"Br. J. Anaesth."},{"issue":"12","key":"10.1016\/j.clineuro.2025.108952_bib29","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.mayocp.2021.08.008","article-title":"Preoperative management of gastrointestinal and pulmonary medications: society for perioperative assessment and quality improvement (SPAQI) consensus statement","volume":"96","author":"Pfeifer","year":"2021","journal-title":"Mayo Clin. Proc."},{"issue":"18","key":"10.1016\/j.clineuro.2025.108952_bib30","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.clineuro.2025.108952_bib31","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00264-016-3153-z","article-title":"Minimally invasive versus open transforaminal lumbar fusion: a systematic review of complications","volume":"40","author":"Hu","year":"2016","journal-title":"Int. Orthop."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725002355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725002355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T14:15:20Z","timestamp":1748009720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725002355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"alternative-id":["S0303846725002355"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108952","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of semaglutide use for weight loss on transforaminal lumbar interbody fusion outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108952"}}